Works matching IS 17921074 AND DT 2025 AND VI 29 AND IP 1


Results: 65
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Single‑center, retrospective, evaluator‑blinded, pilot and pivotal clinical trials: Assessing the mirCaP Kit (hsv2‑miR‑H9/hsa‑miR‑3659) as a diagnostic marker for prostate cancer in patients with PSA levels in the gray zone

    Published in:
    Oncology Letters, 2025, v. 29, n. 1, p. N.PAG, doi. 10.3892/ol.2024.14770
    By:
    • Kim, Won Tae;
    • Kim, Kyeong;
    • Kang, Ho Won;
    • Byun, Young Joon;
    • Piao, Xuan-Mei;
    • Kim, Yong-June;
    • Lee, Sang Cheol;
    • Yun, Seok Joong;
    • Ha, Yun-Sok;
    • Kim, Jiyeon;
    • Kim, Isaac Yi
    Publication type:
    Article
    43
    44
    45
    46

    Neutrophil‑to‑lymphocyte ratio and risk of disease progression in patients with nivolumab‑treated unresectable or recurrent gastric cancer.

    Published in:
    Oncology Letters, 2025, v. 29, n. 1, p. N.PAG, doi. 10.3892/ol.2024.14766
    By:
    • Hayashi, Hirokatsu;
    • Yasufuku, Itaru;
    • Sato, Yuta;
    • Fujibayashi, Seito;
    • Chikaishi, Wakana;
    • Endo, Masahide;
    • Horaguchi, Takeshi;
    • Yokoi, Ryoma;
    • Matsumoto, Keita;
    • Kuno, Masashi;
    • Sengoku, Yuki;
    • Fukada, Masahiro;
    • Asai, Ryuichi;
    • Tajima, Jesse Yu;
    • Makiyama, Akitaka;
    • Kiyama, Shigeru;
    • Tanaka, Yoshihiro;
    • Murase, Katsutoshi;
    • Ishihara, Takuma;
    • Matsuhashi, Nobuhisa
    Publication type:
    Article
    47
    48
    49
    50